Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.39
+0.38 (7.58%)
At close: Nov 26, 2025, 4:00 PM EST
5.50
+0.11 (2.04%)
After-hours: Nov 26, 2025, 7:46 PM EST
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $958.68 million as of November 26, 2025. Its market cap has increased by 266.72% in one year.
Market Cap
958.68M
Enterprise Value
748.65M
1-Year Change
266.72%
Ranking
Category
Stock Price
$5.39
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has increased from $435.34M to $958.68M, an increase of 120.21%. That is a compound annual growth rate of 18.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 958.68M | 380.53% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | 435.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |